JP5025062B2 - Ｎ，ｏ−アミドマロネート白金錯体 - Google Patents

Ｎ，ｏ−アミドマロネート白金錯体 Download PDF

Info

Publication number
JP5025062B2
JP5025062B2 JP2001550236A JP2001550236A JP5025062B2 JP 5025062 B2 JP5025062 B2 JP 5025062B2 JP 2001550236 A JP2001550236 A JP 2001550236A JP 2001550236 A JP2001550236 A JP 2001550236A JP 5025062 B2 JP5025062 B2 JP 5025062B2
Authority
JP
Japan
Prior art keywords
platinum
chelate
complex
polymer
ama
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2001550236A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003530317A5 (enExample
JP2003530317A (ja
Inventor
ドナルド アール． スチュワート，
ジョン アール． ライス，
ジョン ブイ． セイント．ジョン，
Original Assignee
アクセス ファーマシューティカルズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アクセス ファーマシューティカルズ， インコーポレイテッド filed Critical アクセス ファーマシューティカルズ， インコーポレイテッド
Publication of JP2003530317A publication Critical patent/JP2003530317A/ja
Publication of JP2003530317A5 publication Critical patent/JP2003530317A5/ja
Application granted granted Critical
Publication of JP5025062B2 publication Critical patent/JP5025062B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyamides (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2001550236A 2000-01-04 2001-01-04 Ｎ，ｏ−アミドマロネート白金錯体 Expired - Fee Related JP5025062B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17443500P 2000-01-04 2000-01-04
US60/174,435 2000-01-04
PCT/US2001/000284 WO2001049696A1 (en) 2000-01-04 2001-01-04 N,o-amidomalonate platinum complexes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011086844A Division JP2011137046A (ja) 2000-01-04 2011-04-08 Ｎ，ｏ−アミドマロネート白金錯体

Publications (3)

Publication Number Publication Date
JP2003530317A JP2003530317A (ja) 2003-10-14
JP2003530317A5 JP2003530317A5 (enExample) 2008-02-28
JP5025062B2 true JP5025062B2 (ja) 2012-09-12

Family

ID=22636134

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001550236A Expired - Fee Related JP5025062B2 (ja) 2000-01-04 2001-01-04 Ｎ，ｏ−アミドマロネート白金錯体
JP2011086844A Withdrawn JP2011137046A (ja) 2000-01-04 2011-04-08 Ｎ，ｏ−アミドマロネート白金錯体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011086844A Withdrawn JP2011137046A (ja) 2000-01-04 2011-04-08 Ｎ，ｏ−アミドマロネート白金錯体

Country Status (8)

Country Link
US (1) US6692734B2 (enExample)
EP (1) EP1254145A1 (enExample)
JP (2) JP5025062B2 (enExample)
KR (1) KR100729015B1 (enExample)
AU (1) AU2762101A (enExample)
CA (1) CA2396702C (enExample)
WO (1) WO2001049696A1 (enExample)
ZA (1) ZA200205358B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166733B2 (en) * 2000-01-04 2007-01-23 Access Pharmaceuticals, Inc. O,O'-Amidomalonate and N,O-Amidomalonate platinum complexes
US7138520B2 (en) * 2003-01-13 2006-11-21 Massachusetts Institute Of Technology Coordination complexes having tethered therapeutic agents and/or targeting moieties, and methods of making and using the same
US7754684B2 (en) * 2003-06-11 2010-07-13 Access Pharmaceuticals, Inc. Macromolecular platinum chelates
RU2472812C2 (ru) 2005-12-05 2013-01-20 НИТТО ДЕНКО КОРПОРЭЙШН (Джэпэн/Джэпэн) Конъюгаты полиглутамат-аминокислота и способы
DK2155254T3 (da) * 2007-05-09 2013-03-04 Nitto Denko Corp Med platinlægemidler konjugerede polymere
PL2209814T3 (pl) * 2007-11-13 2017-08-31 Bio-Technology General (Israel) Ltd. Proces sterylizacji przez filtrację z rozcieńczaniem dla lepkosprężystych biopolimerów
KR101705077B1 (ko) * 2008-10-07 2017-02-09 렉산 파마슈티컬스, 인코포레이티드 Ｈｐｍａ-도세탁셀 또는 젬시타빈 컨쥬게이트 및 이의 용도
JP5281358B2 (ja) * 2008-10-27 2013-09-04 学校法人常翔学園 高分子、経上皮吸収促進剤、及び医薬用製剤
EP2488207A4 (en) 2009-10-13 2015-06-10 Rexahn Pharmaceuticals Inc POLYMERIC ANTIBODY RELEASE SYSTEMS
JP5684056B2 (ja) 2010-08-16 2015-03-11 株式会社マキタ 手持ち工具
US8946163B2 (en) 2012-11-19 2015-02-03 Mimedx Group, Inc. Cross-linked collagen comprising metallic anticancer agents
US10335433B2 (en) * 2013-04-10 2019-07-02 Mimedx Group, Inc. NDGA polymers and metal complexes thereof
US20160220689A1 (en) * 2013-09-10 2016-08-04 Starpharma Pty Ltd. Macromolecules of dendrimer-platinum conjugates
KR20180019536A (ko) 2015-06-24 2018-02-26 니폰 가야꾸 가부시끼가이샤 신규한 백금(ⅳ) 착물
WO2017047497A1 (ja) 2015-09-14 2017-03-23 日本化薬株式会社 ６配位白金錯体の高分子結合体
EP3706801A4 (en) * 2017-11-08 2022-04-06 L.E.A.F Holdings Group LLC PLATINUM COMPLEXES AND USES THEREOF
CA3106568A1 (en) 2018-07-19 2020-01-23 Starpharma Pty Ltd Therapeutic dendrimer
US12071517B2 (en) 2018-07-19 2024-08-27 Starpharma Pty Ltd. Therapeutic dendrimer
CN113018311A (zh) * 2019-12-25 2021-06-25 沈阳药科大学 顺铂配合物以及顺铂配合物脂质体的制备方法
CN117105797B (zh) * 2023-08-25 2025-09-23 湖南科技大学 一种谷氨酸铂配合物及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63284134A (ja) * 1987-02-25 1988-11-21 ジョンソン　マセイ　インコーポレーテッド 抗腫瘍巨大分子白金化合物
JPS6494A (en) * 1987-03-06 1989-01-05 Tanabe Seiyaku Co Ltd Novel organoplatinum complex
WO1998047537A1 (en) * 1997-04-18 1998-10-29 Access Pharmaceuticals, Inc Polymer-platinum compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO146404C (no) * 1979-10-26 1982-09-22 Dyno Industrier As Bygning for lyddempet skyting.
JPS5667326A (en) * 1979-11-05 1981-06-06 Hitachi Ltd Imide type compound and production thereof
IL67789A (en) 1983-01-31 1986-09-30 Yissum Res Dev Co Amino-substituted malonato platinum(ii)complexes and method for their preparation
US4882447A (en) 1987-02-20 1989-11-21 Tanabe Seiyaku Co., Ltd. Novel organic platinum complex and process for the preparation thereof
IL85595A0 (en) 1987-03-06 1988-08-31 Tanabe Seiyaku Co Organic platinum complex and its preparation
JPH0256421A (ja) * 1988-08-19 1990-02-26 Tanabe Seiyaku Co Ltd 抗腫瘍剤
JPH0267217A (ja) * 1988-09-01 1990-03-07 Tanabe Seiyaku Co Ltd 抗腫瘍剤
US4946954A (en) * 1989-01-17 1990-08-07 Georgetown University Platinum pharmaceutical agents
KR0164460B1 (ko) 1995-10-02 1999-03-20 김은영 고분자 백금 착화합물, 그의 제조방법 및 그를 유효성분으로 하는 항암제

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63284134A (ja) * 1987-02-25 1988-11-21 ジョンソン　マセイ　インコーポレーテッド 抗腫瘍巨大分子白金化合物
JPS6494A (en) * 1987-03-06 1989-01-05 Tanabe Seiyaku Co Ltd Novel organoplatinum complex
WO1998047537A1 (en) * 1997-04-18 1998-10-29 Access Pharmaceuticals, Inc Polymer-platinum compounds

Also Published As

Publication number Publication date
AU2762101A (en) 2001-07-16
ZA200205358B (en) 2003-08-20
EP1254145A1 (en) 2002-11-06
JP2003530317A (ja) 2003-10-14
KR20020082208A (ko) 2002-10-30
KR100729015B1 (ko) 2007-06-14
WO2001049696A1 (en) 2001-07-12
US6692734B2 (en) 2004-02-17
JP2011137046A (ja) 2011-07-14
CA2396702C (en) 2010-03-23
CA2396702A1 (en) 2001-07-12
US20010038830A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
JP2011137046A (ja) Ｎ，ｏ−アミドマロネート白金錯体
US20070197427A1 (en) O,o'-amidomalonate and n,o-amidomalonate platinum complexes
KR101444274B1 (ko) 약제복합체용 블록 공중합체 및 의약조성물
Song et al. A cross-linked polymeric micellar delivery system for cisplatin (IV) complex
US7754684B2 (en) Macromolecular platinum chelates
Song et al. Synthesis, characterization, and tumor selectivity of a polyphosphazene–platinum (II) conjugate
BR112017023250B1 (pt) Derivado, sistema de liberação de fármaco, kit, composição farmacêutica e uso do referido derivado
US20170100485A1 (en) Metal-polysaccharide conjugates: methods for cancer therapy
Gou et al. Evaluation of interactions between platinum-/ruthenium-based anticancer agents and human serum albumin: development of HSA carrier for metal-based drugs
EP3976024A1 (en) Oxaliplatin containing therapeutic polyamidoamine (pamam) dendrimers and production method thereof
AU2006222657B2 (en) N,O-amidomalonate platinum complexes
Pan et al. In Vivo Surface-Reactive Nanoparticles of Polypeptide-Drug Conjugates Adopt α-Helical Structures to Enhance Lysosomal Membrane Permeabilization and Anti-Tumor Efficacy
AU2012202161A1 (en) O,O'-amidomalonate and N,O-amidomalonate platinum complexes
JP2019156771A (ja) ペメトレキセド−ヒアルロン酸結合体
An et al. Development of Orally Absorbable Cisplatin Prodrugs Enclosed in Liposomes and Their Application as a Treatment for Lung Cancer
Lerchbammer-Kreith Platinum (IV) complexes conjugated to polymers designed as novel drug delivery systems for preclinical cancer therapy evaluation
PL227543B1 (pl) Sposób wytwarzania koniugatu fibrynogenu glikowanego glukozą z metotreksatem

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071227

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101216

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20101215

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110315

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110323

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110408

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110707

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111006

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111014

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111104

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111202

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120524

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120619

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150629

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees